Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03290417 · ClinicalTrials.gov registry record · NA
Correlative Analysis of the Genomics of Vitamin D and Omega-3 Fatty Acid Intake in Prostate Cancer
A NA study, sponsored by Case Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 37
- Enrollment target
NCT03290417 is a NA study that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 37 participants.
The verdict
NCT03290417, a NA study, has completed, sponsored by Case Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
Study Summary
The purpose of this study is to see if eating vitamin D, omega 3 and turmeric (curcumin) slows the growth of prostate cancer in men on active surveillance.
Interventions
- DIETARY_SUPPLEMENT Omega-3
- DIETARY_SUPPLEMENT Vitamin D
- DIETARY_SUPPLEMENT Turmeric
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2017-09-07 |
| Est. Completion | 2019-12-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03290417
The ClinicalTrials.gov registry entry for NCT03290417 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Omega-3 is the first listed.
NCT03290417 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03290417 about?
NCT03290417 is a clinical study titled "Correlative Analysis of the Genomics of Vitamin D and Omega-3 Fatty Acid Intake in Prostate Cancer". The purpose of this study is to see if eating vitamin D, omega 3 and turmeric (curcumin) slows the growth of prostate cancer in men on active surveillance.
What is the current status of trial NCT03290417?
This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2017-09-07. Estimated completion is 2019-12-20.
What interventions are being tested in trial NCT03290417?
The interventions under investigation include: Omega-3 (DIETARY_SUPPLEMENT), Vitamin D (DIETARY_SUPPLEMENT), Turmeric (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03290417?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.